Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative NeoplasmsEmbolism and Thrombosis, Hemic and Lymphatic Diseases, Hemorrhage, Myeloproliferative Disorders, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, acquired polycythemia vera, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, cardiovascular disorder, cellular phase chronic idiopathic myelofibrosis, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, neoplasm, primary myelofibrosis, thrombocytosis disease, vascular disorder, venous thromboembolismRecruitingPhase 32026-03-20NCT05198960

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
University Hospital, Brest146

42 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Henri Becquerel de RouenRouenFrance1
Centre Léon Bérard LyonLyonFrance1
CH Bretagne Atlantique VannesVannesFrance1
CH d'AnnecyAnnecyFrance1
CH d'ArgenteuilArgenteuilFrance2
CH d'AvignonAvignonFrance3
CH de BéziersBéziersFrance1
CH de la Côte Basque BayonneBayonneFrance1
CH de MorlaixMorlaixFrance1
CH de PerpignanPerpignanFrance2
CH de PérigueuxPérigueuxFrance2
CH de RochefortRochefortFrance1
CH de RoubaixRoubaixFrance4
CH de VersaillesVersaillesFrance1
CH Le MansLe MansFrance6
CH LibourneLibourneFrance3
CH Paul-Brousse (APHP)VillejuifFrance1
CHD Vendée La Roche Sur YonLa Roche-sur-YonFrance1
CHIC de QuimperQuimperFrance1
CHR d'OrléansOrléansFrance3
CHU BordeauxBordeauxFrance2
CHU BrestBrestFrance30
CHU d'AngersAngersFrance25
CHU de Clermont-FerrandClermont-FerrandFrance5
CHU de Limoges - Hôpital DupuytrenLimogesFrance2